[Letrozole versus gonadotropin-releasing hormone antagonist during luteal phase in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial].
Z X Cheng, Grace Kong, Chenhao Zhang, Yiqing Zhao
Abstract
Z X Cheng, Grace Kong, Chenhao Zhang, Yiqing Zhao
Abstract
Letrozole has the same efficiency as GnRH antagonist for the prevention of OHSS, faster and cheaper to use, but its efficacy seems not to be related to the suppression of steroidogenic during the luteal phase.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Letrozole has the same efficiency as GnRH antagonist for the prevention of OHSS, faster and cheaper to use, but its efficacy seems not to be related to the suppression of steroidogenic during the luteal phase.
Key concepts: Ovarian hyperstimulation syndrome, Letrozole, Gonadotropin-releasing hormone antagonist, Medicine, Intracytoplasmic sperm injection, Antagonist, Luteal phase, In vitro fertilisation